|
HS Code |
782261 |
| ProductName | Ethyl 1H-Tetrazole-5-Carboxylate |
| CASNumber | 35250-75-2 |
| MolecularFormula | C4H6N4O2 |
| MolecularWeight | 142.12 |
| Appearance | White to off-white solid |
| MeltingPoint | 94-96°C |
| Solubility | Soluble in organic solvents such as ethanol and DMSO |
| Purity | Typically ≥98% |
| SMILES | CCOC(=O)c1nnn[nH]1 |
| InChI | InChI=1S/C4H6N4O2/c1-2-10-4(9)3-5-6-7-8-3/h2H2,1H3,(H,8,5,6,7) |
| StorageTemperature | 2-8°C |
| Synonyms | Ethyl tetrazole-5-carboxylate |
As an accredited Ethyl 1H-Tetrazole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ethyl 1H-Tetrazole-5-Carboxylate is packaged in a 25g amber glass bottle with a secure screw cap and safety labeling. |
| Shipping | Ethyl 1H-Tetrazole-5-Carboxylate is shipped in tightly sealed containers under cool, dry conditions to prevent moisture absorption and degradation. Packaging complies with regulations for safe transport of chemicals. Secure labeling and documentation accompany the shipment to ensure proper handling, storage, and compliance with international and local chemical shipping requirements. |
| Storage | Ethyl 1H-Tetrazole-5-Carboxylate should be stored in a tightly closed container, in a cool, dry, well-ventilated area, away from sources of ignition, heat, and incompatible substances such as strong oxidizers. Protect from moisture and light. Recommended storage temperature is 2-8°C (refrigerated). Properly label the container and follow all standard laboratory safety protocols. |
| Purity 99%: Ethyl 1H-Tetrazole-5-Carboxylate with purity 99% is used in pharmaceutical intermediate synthesis, where it enhances reaction efficiency and yield. Melting point 147°C: Ethyl 1H-Tetrazole-5-Carboxylate with melting point 147°C is used in solid-phase peptide synthesis, where it ensures thermal stability during coupling reactions. Particle size <50 microns: Ethyl 1H-Tetrazole-5-Carboxylate with particle size below 50 microns is used in formulation of fine chemical reagents, where it provides uniform blending and dispersion. Moisture content ≤0.5%: Ethyl 1H-Tetrazole-5-Carboxylate with moisture content not exceeding 0.5% is used in active pharmaceutical ingredient manufacturing, where it reduces hydrolytic degradation risks. Stability temperature up to 120°C: Ethyl 1H-Tetrazole-5-Carboxylate stable up to 120°C is used in chemical process development, where it maintains integrity under elevated processing temperatures. HPLC assay ≥98%: Ethyl 1H-Tetrazole-5-Carboxylate with HPLC assay of at least 98% is used in heterocyclic compound research, where it ensures reliable and reproducible results. Low residual solvent <0.1%: Ethyl 1H-Tetrazole-5-Carboxylate with residual solvent below 0.1% is used in fine chemical production, where it meets stringent regulatory safety standards. Molecular weight 143.1 g/mol: Ethyl 1H-Tetrazole-5-Carboxylate with molecular weight of 143.1 g/mol is used in combinatorial chemistry applications, where it allows precise formulation and stoichiometric calculations. |
Competitive Ethyl 1H-Tetrazole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Discovering a reliable entry point into tetrazole chemistry isn’t always as straightforward as pulling a bottle off the shelf. Over the years, I’ve noticed how crucial it is to have access to building blocks that actually deliver on consistency and purity. Ethyl 1H-Tetrazole-5-Carboxylate (ETC) brings a kind of confidence to synthesis work that’s tough to overstate. For professionals downstream in medicinal or agrochemical research, the value shows itself each time reactions progress without unwelcome surprises.
With its tetrazole ring and ester tail, ETC stands out structurally from more conventional carboxylic acids and their derivatives. This backbone gives researchers room to maneuver during functional group manipulation. Usually found as a white to off-white powder, ETC boasts dependable purity in reputable lots, which matters if you care about reaction predictability. A melting point hovering in the 110-115°C range often serves as a quick checkpoint for identity.
I’ve seen ETC cited in a surprising number of research papers — particularly as a midpoint in the synthesis of pharmaceutical intermediates. Tetrazole rings have become popular as bioisosteres, stepping in for carboxylic acids in drug molecules aiming for better metabolic stability or altered solubility profiles. ETC’s ethyl ester group grants an extra layer of versatility: you can hydrolyze it to get the free acid, or drive it into further transformations if a more customized derivative is needed.
In practice, labs commonly turn to ETC during the preparation of substituted tetrazole compounds, many of which have found their way into antihypertensive drugs or components in antifungal research. The unique nitrogen-rich ring system allows for interesting hydrogen bonding interactions — a fact not lost on medicinal chemists designing molecules to bind tightly to their biological targets.
Comparing ETC to other tetrazoles such as 1H-Tetrazole itself or its methyl ester cousin, subtle but important differences emerge. The ethyl ester extends the molecule’s reach. You get increased lipophilicity versus the sodium salt form, not to mention the ability to enter selective alkylations or behave differently in solvent systems. The ethyl group also resists hydrolysis a bit more than its methyl sibling, which can buy an extra measure of control during multi-step syntheses.
My own work with ETC in the development of heterocyclic compounds underscored the importance of reliable purification. ETC’s crystalline nature makes isolation relatively straightforward compared to stickier, oilier alternatives. A well-formed solid helps avoid debugging TLCs and repeat crystallizations, saving hours of troubleshooting.
Many researchers I’ve spoken to highlight the breadth of grades for ETC available on the market. Some sources offer material with watermarking — stripes in spectral purity or batch consistency — while better providers give material that meets or outpaces standards for high-throughput synthesis. In the competitive world of pharma, low levels of side-products, especially from residual hydrazine-based routes, can make or break a project. Extra attention to supplier choice becomes part of the routine, not a luxury.
As far as storage goes, ETC benefits from its solid, relatively stable nature. I’ve never had issues with short-term bench exposure, but making a habit of sealing it tight and keeping it out of warm, humid environments pays off. Impurities tend to creep up in any material that lingers too long in uncertain conditions. Freshly opened ETC, measured with care, avoids headaches later in a synthetic campaign.
In pharmaceutical research, ETC’s value isn’t just on the benchtop. It contributes to the exploration of new drug candidates that target enzymes and receptors where the tetrazole group can act as a carboxylate mimic. The replacement sometimes extends the patent life of existing molecules, a maneuver often favored by intellectual property strategists. I’ve observed patent filings that highlight the role of ETC-derived units in both central nervous system and cardiovascular drug discovery.
On the agrochemical side, ETC frequently serves as a precursor for synthesizing plant-protective agents, particularly when scientists seek to incorporate azole and tetrazole motifs for improved enzyme inhibition. For labs lacking the infrastructure to handle more reactive azide intermediates, ETC delivers much of the same chemistry, but with greater handling safety and easier scale-up potential.
Some research groups gravitate toward simple tetrazoles or their sodium salts, especially where water solubility matters. By contrast, ETC caters to those with a preference for working in organic phase or targeting transformations that need ester reactivity but balk at free acids’ tendency to promote aggregation or unwanted side reactions. Where methyl esters offer greater volatility and sometimes finicky purification, the ethyl group of ETC provides an edge in stability without making it cumbersome.
ETC’s intermediate polarity places it in a sweet spot: it stays soluble enough in a wide range of organic solvents, yet precipitates cleanly out with proper antisolvents. I’ve found that this helps clear up reaction workups, especially after a tough reduction or amidation sequence, giving greater working yields with cleaner spectra.
In drug synthesis, ETC usually sees deployment as the starting block for ring construction. Ester hydrolysis lets chemists reach the corresponding acid, which slots easily into peptide coupling or other condensation reactions. Modifications at the ethyl group become possible, though most users capitalize on clean conversion to acids or amides. For those exploring prodrug strategies, maintaining the ester group until the last possible moment often pays dividends in solubility or permeability during biological testing.
For those advancing catalyst development, ETC acts as a route to embed tetrazole scaffolds into ligands, sometimes leading to improved electron density or altered binding behaviors. Using ETC allows these modifications to take place with fewer changes downstream, which streamlines screening.
Buying ETC from less-vetted sources occasionally leads to surprises in purity. Extra weight from co-crystallized solvents or missed side-products sometimes impacts downstream analytical results. By now, I always prioritize suppliers who share their certificate of analysis and supply relevant spectra. Chromatographic purity and minimal residual solvents can set the bar for reliable data.
While ETC itself has no glaring handling dangers in standard laboratory use, every new tech or student in the lab needs upfront supervision with nitrogen-rich compounds. Any process that generates dust may benefit from gloves and a fume hood, since tetrazole derivatives sometimes escape rigorous toxicity study. For any upscaling efforts, consultation with local regulations and industrial hygiene officers seems prudent — not because ETC proves unruly, but because scale amplifies any risk.
Growing demand for tetrazole chemistry in both pharmaceuticals and crop science has expanded the market for ETC. I remember a time when sourcing even a gram felt like a drawn-out negotiation. Now, bulk quantities line the catalogs of several well-known chemical suppliers, often offered at higher purity and more competitive prices due to improved manufacturing methods.
Still, putting trust in a supplier goes beyond price. I’ve learned from colleagues who ran intractable side-reactions or off-target byproducts simply because an ETC lot came spiked with minuscule amounts of byproducts. Comprehensive COAs that display TLC, HPLC, and sometimes NMR snapshots assure me that what arrives by courier matches what the catalog promises.
To hedge against shortages or shifting international regulations around nitrogen-rich compound shipping, many research groups establish relationships with more than one vendor. I favor building these relationships while times are good, reducing headaches if supply lines choke up. In some regions, tariffs or import restrictions add extra challenges — a problem that tends to surface only after the grant proposal funds have cleared.
Modern chemistry cannot ignore sustainability and safety concerns. Ethical sourcing now joins cost and purity as a core pillar of responsible work. For ETC, sustainable manufacturing practices tie back to the minimization of hazardous byproducts, proper solvent reclamation, and low-energy synthetic routes. Genuine supplier transparency about their practices boosts my confidence, especially since some classic tetrazole syntheses once relied on hazardous precursors like hydrazoic acid.
Waste disposal grows more complex as more compounds move from the benchtop to kilogram-scale production. ETC itself doesn’t usually present a major waste stream concern, but its syntheses often do. Research groups working with regulatory frameworks stress the importance of cradle-to-grave waste tracking, particularly for submissions to green chemistry initiatives or regulatory agencies monitoring persistent contaminants.
It’s obvious that synthetic methods evolve each decade, yet many industry staples resist modernization. I’d like to see greener, safer, and more selective pathways to ETC that avoid not just the worst reagents, but also increase atom economy. Several academic papers in recent years hint at catalytic routes that use less expensive, less hazardous precursors.
For professional consumers, sending a consistent signal to suppliers about these expectations can actually accelerate progress. More than once, I’ve seen academic consortia pool purchasing power to demand safer, higher quality materials. Such strategies help level the playing field for smaller research groups priced out of premium markets.
With choices in synthetic intermediates growing, the reasons behind picking ETC stand out more than they used to. For one, ETC provides a balance between reactivity and manageability that sodium tetrazolide or free acids sometimes lack. By permitting late-stage functionalization, ETC allows medicinal and materials chemists to adapt to evolving research requirements without doubling back to route scouting every project.
The ester group’s relative robustness against accidental hydrolysis means a compound can wait on the shelf a bit longer and endure less-than-ideal storage without decomposing. Each time this spares a resynthesis, limited resources stretch a bit further.
Learning through direct application – and exchanging tips with those who have run the same routes with ETC – has had the greatest impact on my work. There are no substitutes for field-tested advice, whether it’s about best purification solvents, clever crystallization techniques, or avoiding cross-contamination during product isolation. Online forums and conference poster sessions have become prime venues for troubleshooting reaction bottlenecks.
This kind of community sharing pushes innovation faster than one lab can alone. I’ve picked up methods for improved yields and safer waste neutralization just by listening in on colleagues who solved the same set of problems years earlier. Their willingness to share experience around ETC, from prep to disposal, has raised standards and fostered better data trustworthiness.
While ETC itself doesn’t always draw direct regulatory scrutiny, its role as a precursor keeps it in the conversation. With intellectual property protections getting tighter around well-known pharmaceutical and agrochemical derivatives, ETC pops up in composition claims or described as a novel starting material. Familiarity with ETs synthetic history sometimes gives an edge to researchers seeking “freedom to operate.” I’ve sat in strategy sessions where patent lawyers picked apart ETC routes line by line, parsing which transformations are novel and which count as ordinary chemical development.
Researchers aiming for the clinic need traceable supply chains and confidence that ETC’s purity records will pass regulatory inspection. Having paperwork that tracks every step — from sourcing to final application — can prevent regulatory headaches that derail otherwise solid science. Some of this paperwork stems from experience: older chemists who recall incidents of industrial contamination remind the next generation not to skip supplier vetting for the sake of speed.
As chemical research stretches into new frontiers — such as bio-orthogonal labeling or targeted radiopharmaceuticals — the steady performance of ETC as a scaffold gives young researchers room to innovate. High-purity ETC makes it possible to attempt more intricate couplings or to design molecules for imaging or drug delivery projects. In teaching settings, ETC’s robust safety profile makes it suitable for inclusion in advanced synthesis labs, giving students firsthand insight into modern heterocyclic chemistry.
Reflecting on my own transition from student to professional researcher, I’ve seen ETC move from a footnote in obscure syntheses to a mainstay in well-funded labs. Its adoption parallels the increased demand for safer, more modular synthetic building blocks. Every successful synth highlights why quality, reliability, and strategic sourcing matter not just for one lab, but for the wider community of chemists pushing the discipline forward.
Over years of research, ETC has emerged not just as a reagent, but as a tool that streamlines the complex path of molecular discovery. For those committed to advancing synthetic chemistry, looking beyond catalog descriptions — and learning from collective experience — marks the real difference between routine results and breakthroughs that matter.